Kalmegh / Andrographis: Effects, Application, and Quality

Kalmegh / Andrographis: Botany and Origin

*Andrographis paniculata*, known in Ayurveda as Kalmegh and in Traditional Chinese Medicine (TCM) as Chuan Xin Lian, is an annual herbaceous plant from the Acanthaceae family. This remarkable plant is a true gift of nature, native to South and Southeast Asia, where it has been valued for its health-promoting properties since time immemorial.

Its homeland extends across countries such as India, Sri Lanka, Pakistan, Thailand, Malaysia, and Indonesia. Today, Kalmegh is also cultivated in China and other parts of Asia, underscoring its global importance. For medicinal purposes, mainly the leaves and aerial parts of the plant, i.e., stems and flowers, are used.

As a robust plant, *Andrographis paniculata* thrives in tropical to subtropical climates and prefers well-drained, loamy soils. It can grow up to one meter tall and is relatively easy to cultivate. Harvesting typically occurs when the plant is in full bloom, approximately 90 to 120 days after planting. After harvesting, the aerial parts are dried and processed into powders, extracts, or tinctures, which form the basis for many traditional and modern dietary supplements. Sustainable harvesting practices are crucial to ensure the long-term availability and quality of this valuable plant.

The Power of Andrographolides

The remarkable pharmacological activities of *Andrographis paniculata* are primarily due to a group of diterpenoid lactones known as **andrographolides**. These bioactive compounds give Kalmegh its intense bitterness and its diverse properties. The most important and best-studied andrographolides are:

• **Andrographolide:** The most abundant and pharmacologically most active compound.
• **Neoandrographolide**
• **Deoxyandrographolide**
• **14-Deoxy-11,12-didehydroandrographolide**

In addition to andrographolides, Kalmegh also contains other valuable secondary plant compounds such as flavonoids (e.g., andrograpanin, apigenin), polysaccharides, glycerides, and sterols, which round off the synergistic profile of the plant. The quality of Kalmegh extracts is often determined by their standardized total content of andrographolides, which typically ranges between 5% and 30%.

The King of Bitters: Traditional Applications

In the annals of traditional medicine, *Andrographis paniculata* holds a place of honor. Its epithet "King of Bitters" is not just an allusion to its intensely bitter taste, but also to its powerful and versatile healing properties, which have been used in various healing systems for centuries.

An Integral Part of Ancient Healing Systems

• Ayurveda (India): Under the name Kalmegh, the plant has been used for centuries to treat a wide range of ailments, particularly fever, liver diseases, and infections. It is considered a "bitter tonic" that helps balance the Pitta and Kapha doshas.
• Traditional Chinese Medicine (TCM): As Chuan Xin Lian, Kalmegh is used to "clear heat," "resolve toxicity," and reduce inflammation. It is often prescribed for colds, flu, sore throats, and digestive problems.
• Unani Medicine: Here too, Kalmegh is used for fever, liver complaints, and "blood purification."
• Thai Traditional Medicine: Used for fever, sore throats, and infections.

Traditional Indications and Preparations

Traditionally, Kalmegh is used for a variety of indications, including fever, common cold, flu, sore throat, cough, bronchitis, sinusitis, digestive problems (dyspepsia, diarrhea), to support the liver (hepatoprotective), for skin infections, parasitic infections, and as an anti-inflammatory agent.

Traditionally, it was prepared as a decoction (boiled in water), infusion (steeped in hot water), powder, or as fresh juice from the leaves. In modern traditional medicine, Kalmegh is also available in tablet or capsule form, which simplifies administration.

Cultural Significance

The intense bitterness of Kalmegh is not interpreted as a defect in many cultures, but rather as a sign of its potent medicinal properties. It is believed to be particularly effective in "clearing heat" and "detoxifying" the body. Kalmegh is often used during seasonal changes or when the body feels run down, reflecting the cultural belief in its strengthening and protective properties.

What Science Says: Kalmegh in Studies

Modern science has extensively investigated *Andrographis paniculata* to substantiate its traditional uses with evidence-based findings. The research focuses on its immunomodulatory, anti-inflammatory, and antiviral properties, particularly in the context of respiratory tract infections.

Clinical Studies on Colds and Upper Respiratory Tract Infections (URTIs)

Several studies have investigated the efficacy of Kalmegh in alleviating symptoms of colds and uncomplicated upper respiratory tract infections.

Anti-inflammatory Properties

Although direct clinical studies from EU/G7 countries focusing exclusively on *Andrographis* for general inflammation in humans are less common than those for URTIs, its anti-inflammatory mechanisms are well-established in preclinical studies. Research groups at institutions such as the University of Heidelberg and various British universities have significantly contributed to elucidating the molecular mechanisms of andrographolides, including their ability to inhibit NF-κB signaling pathways, which play a key role in inflammatory processes.

Systematic Reviews and Meta-Analyses

Several systematic reviews and meta-analyses have confirmed the efficacy of *Andrographis paniculata* extracts – often in combination with other herbs such as *Eleutherococcus senticosus* – in reducing the symptoms and duration of colds and uncomplicated URTIs.

Important Preclinical Studies

• Anti-inflammatory: Andrographolides have been shown to inhibit pro-inflammatory mediators (e.g., TNF-α, IL-1β, IL-6, NO, PGE2) by suppressing NF-κB activation and MAPK signaling pathways in various cell lines and animal models.
• Immunomodulatory: Studies suggest that Kalmegh can enhance immune responses by increasing the activity of natural killer cells, macrophages, and T-lymphocytes and promoting cytokine production.
• Antiviral: *In vitro* studies have shown direct antiviral activity against various viruses, including influenza viruses, herpes simplex viruses, and potentially some coronaviruses, by inhibiting viral replication and entry.
• Hepatoprotective (liver-protective): Animal studies have demonstrated Kalmegh's ability to protect liver cells from damage caused by various toxins, likely due to its antioxidant and anti-inflammatory properties.

Assessment of Evidence Quality

• Cold/Upper Respiratory Tract Infections: **Strong/Moderate**. Several well-designed clinical studies and meta-analyses support its efficacy in reducing symptom severity and duration.
• Immune Support (general): **Moderate**. Supported by immunomodulatory mechanisms and clinical results in URTIs.
• Anti-inflammatory (general): **Moderate/Preliminary**. Strong preclinical evidence, but further direct clinical studies are needed for specific inflammatory diseases.
• Liver Health: **Preliminary/Traditional**. Strong traditional use and promising animal studies, but human clinical evidence is limited.
• Antiviral (direct): **Preliminary**. Primarily *in vitro* and animal studies; human clinical evidence is emerging but not yet conclusive for specific viral infections beyond the common cold.

Regulatory Status in the EU

The regulatory landscape for herbal ingredients in the EU, including *Andrographis paniculata*, is complex. It strictly distinguishes between food supplements and medicinal products.

EFSA (European Food Safety Authority)

Currently, there are **no specific, EFSA-approved health claims** for *Andrographis paniculata* under Regulation (EC) No. 1924/2006. Many claims submitted for botanicals, including Kalmegh, have been "on hold" pending further scientific assessments, or have been rejected due to insufficient evidence to establish a cause-and-effect relationship under the strict criteria of the EFSA. Claims regarding immune and respiratory health, as well as antioxidant properties, are often submitted but rarely approved for botanicals.

EU Novel Food Status

*Andrographis paniculata* is **not considered a novel food** in the EU. It has a history of safe use in the European Union as a food ingredient or food supplement prior to May 1997. This means it can be legally marketed without Novel Food authorization, provided it complies with other relevant food laws.

Maximum Permissible Dosages in Food Supplements (EU)

There is **no harmonized EU-wide maximum dose** for *Andrographis paniculata* in food supplements. Member states may have their own national regulations or guidelines on maximum daily doses, particularly regarding the content of active compounds such as andrographolides. This leads to variability in the EU market.

German BfR (Federal Institute for Risk Assessment) Positions

The **German Federal Institute for Risk Assessment (BfR)** generally advises caution with high doses and long-term use of plant-based substances, especially those with potent pharmacological activity. While there is no specific, overarching BfR position paper exclusively on *Andrographis paniculata* for food supplements, the general recommendation is to adhere to the manufacturer's consumption guidelines and to seek medical advice in case of uncertainties or pre-existing conditions.

Optimal Use of Kalmegh

Although there are no harmonized EU-wide dosage recommendations, common application practices for Kalmegh are based on traditional knowledge and findings from scientific studies. The dosage often depends on the form of the extract and its standardization to andrographolides.

Recommended Dosage (Example)

Creative Applications for Enhanced Well-being

Kalmegh can be integrated into your daily routine in various ways to optimally utilize its natural bitter compounds.

Frequently Asked Questions about Kalmegh